Illumina India Biotechnology Private Limited, a active foreign private limited company, was established on 20 June 2018 in Sector -45, Haryana, India. Engaging in medical equipment retail & distribution within the professional, scientific and technical sector, it holds CIN: U51100HR2018FTC074675. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹13.00 Cr and a paid-up capital of ₹4.99 Cr.
It upholds a compliant status. Employing 29 professional, Its leadership includes Frederic Didier Mahieu (Director), Suresh Venkata Gadamsetti (Director), Amitabh Rath (Additional Director). Past directors included Boon Kheng Yim, Abhishek Gupta, Frederic Didier Mahieu. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor, Plot No. 4, Minarch Tower, Sector 44, Sector -45, Haryana, 122003.
U51100HR2018FTC074675
074675
20 June 2018
₹13.00 Cr
₹4.99 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Illumina India Biotechnology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Frederic Didier Mahieu | Director | 20 Nov 2023 | Current |
| Suresh Venkata Gadamsetti | Director | 02 May 2024 | Current |
| Amitabh Rath | Additional Director | 08 Sep 2025 | Current |
| Ramesh Thamotharan | Additional Director | 03 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 14 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 15 Apr 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2024 | Past |
| Pramod Abcsdd | Director | 04 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Illumina India Biotechnology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 316.12% increase. The company also saw a substantial improvement in profitability, with a 167% increase in profit. The company's net worth Soared by an impressive increase of 98.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Illumina India Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Illumina India Biotechnology has a workforce of 29 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Illumina India Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Illumina India Biotechnology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Amitabh Rath was appointed as a Additional Director was appointed as a Additional Director on 08 Sep 2025 & has been associated with this company since 3 months 17 days . was recorded as a recent event.
Ramesh Thamotharan was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2025 & has been associated with this company since 3 months 22 days . was recorded as a recent event.
Illumina India Biotechnology Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Suresh Venkata Gadamsetti was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 7 months . was documented.
The activity Illumina India Biotechnology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Frederic Didier Mahieu was appointed as a Director was appointed as a Director on 20 Nov 2023 & has been associated with this company since 2 years 1 month . was recorded as a recent event.
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test.......
When you're the first to bring Illumina's Genome Sequencing to South Asia and you're excited to launch KaryoSeq for prenatal and newborn conditions. NovaSeq X Plus is powerful and can do a lot of genomes quickly, making genomics more accessible. MedGenome is all about innovation and affordability, and KaryoSeq is another step in that direction..
The CIN of Illumina India Biotechnology Private Limited is U51100HR2018FTC074675.
Illumina India Biotechnology Private Limited is headquartered at 2Nd Floor, Plot No. 4, Minarch Tower, Sector 44, Sector -45, Haryana, 122003.
Illumina India Biotechnology Private Limited was incorporated on 20 June 2018.
The current directors of Illumina India Biotechnology Private Limited are
The primary industry of Illumina India Biotechnology Private Limited is Professional, Scientific And Technical.
Illumina India Biotechnology Private Limited is unlisted.
The authorized capital of Illumina India Biotechnology Private Limited is ₹13.00 Cr, and the paid-up capital is ₹4.99 Cr.
The compliance status of Illumina India Biotechnology Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX